Skip to main content
Premium Trial:

Request an Annual Quote

Epicentre licenses Reagents to DuPont

NEW YORK, April 19 (GenomeWeb News) - DuPont has taken a license from Epicentre Biotechnologies to use its EZ-Tn5 and HyperMu transposon tools, Epicentre said today.


Epicentre develops, manufactures, and sells enzyme systems for life science research. The company said that DuPont will use the reagents to create new biocatalysts.


Financial details of the agreement were not released.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.